A.D.A.M. receives 510 (K) eligibility from FDA for 3D printed bones

Connecticut-based 3D bioprinting firm A.D.A.M. (Advanced Development of Additive Manufacturing) has received 510 (K) clearance from the U.S. Food and Drug Administration (FDA) for its 3D printed bioceramic and modified biopolymer bone implants. A.D.A.M.’s vision is to eventually enable patients to have their tissues modeled using MRI and CAT scans stored on its A.D.A.M. digital […]

from 3D Printing Industry https://bit.ly/3dLKO5f